Cpr Laboratories Profile
Key Indicators
- Authorised Capital ₹ 4.70 Cr
- Paid Up Capital ₹ 4.69 Cr
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 8.50 Cr
- Revenue Growth 2344.33%
- Profit Growth 72.23%
- Ebitda 2858.87%
- Net Worth -2.43%
- Total Assets 21.68%
About Cpr Laboratories
Cpr Laboratories Private Limited (CLPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 March 2016 (Eight years and 11 months 14 days old ). Its registered office is in Visakhapatnam, Andhra Pradesh, India.
The Corporate was formerly known as Cpr Laboratories (Opc) Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 4.70 Cr and a paid-up capital of Rs 4.69 Cr.
The company currently has active open charges totaling ₹8.50 Cr.
Ravi Dalai and Vijayakumar Dalai serve as directors at the Company.
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100AP2016PTC098502
- Company No.
098502
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Mar 2016
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Cpr Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravi Dalai  | Director | 11-Mar-2016 | Current |
| Vijayakumar Dalai | Additional Director | 16-Aug-2016 | Current |
Financial Performance of Cpr Laboratories.
Cpr Laboratories Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 2344.33% increase. The company also saw a substantial improvement in profitability, with a 72.23% increase in profit. The company's net worth dipped by a decrease of 2.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cpr Laboratories?
In 2020, Cpr Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹8.50 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 4.46 Cr
- Ifci Limited : 4.04 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jul 2023 | Ifci Limited | ₹4.04 Cr | Open |
| 10 Feb 2017 | Others | ₹4.46 Cr | Open |
How Many Employees Work at Cpr Laboratories?
Cpr Laboratories has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cpr Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cpr Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.